Olusegun Gafar Adebayo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Olusegun Gafar Adebayo has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
Wadioni Aduema
10 shared publications- Benneth Ben-Azu
DELSU Joint Canada‐Israel Neuroscience and Biopsychiatry Laboratory, Department of Pharmacology, Faculty of Allied Health Sciences, College of Health Sciences Delta State University Abraka Delta State Nigeria
7 shared publications Iheanyichukwu Wopara
Department of Biochemistry, Faculty of Sciences, River State University, Port Harcourt, Nigeria
7 shared publicationsAjirioghene E. Akpotu
5 shared publicationsElizabeth B. Umoren
Neurophysiology Unit, Department of Physiology, Faculty of Basic Medical Sciences PAMO University of Medical Sciences Port‐Harcourt Nigeria
5 shared publications- Abayomi Mayowa Ajayi
Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria
4 shared publications
Latest Publications
- Open Access
- 9 September 2025
- Published by Taylor & Francis in Egyptian Journal of Basic and Applied Sciences
- Vol. 12 (1) , 317-336
Alleviation of cholinergic/GABAergic neurotransmitter alterations and behavioral deficit in mice co-exposed to food colors by quercetin pharmacotherapy
- 9 September 2025
- Published by Taylor & Francis in Egyptian Journal of Basic and Applied Sciences
- Vol. 12 (1) , 317-336
Open AccessAlleviation of cholinergic/GABAergic neurotransmitter alterations and behavioral deficit in mice co-exposed to food colors by quercetin pharmacotherapy
- Open Access
- 21 February 2025
- Published by Springer Nature in Nutrire
- Vol. 50 (1) , 1-12
Systemic exposure to rotenone toxicity induces gastro-inflammatory damage in mice: protective response of Zingiber officinale Roscoe extract
- 21 February 2025
- Published by Springer Nature in Nutrire
- Vol. 50 (1) , 1-12
Open AccessSystemic exposure to rotenone toxicity induces gastro-inflammatory damage in mice: protective response of Zingiber officinale Roscoe extract
- Open Access
- 18 December 2024
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 18, 66-77
Ginkgolide B as a biopsychosocial treatment salvages repeated restraint stress-induced amygdalar anomalies in mice
- 18 December 2024
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 18, 66-77
Open AccessGinkgolide B as a biopsychosocial treatment salvages repeated restraint stress-induced amygdalar anomalies in mice
- Open Access
- 5 November 2024
- Published by Springer Nature in Discover Medicine
- Vol. 1 (1) , 1-15
Trans-cinnamaldehyde attenuates neuronal cytotoxicity and memory impairment in comorbid exposure to sleep-deprivation and formalin inhalation in rat model
- 5 November 2024
- Published by Springer Nature in Discover Medicine
- Vol. 1 (1) , 1-15
Open AccessTrans-cinnamaldehyde attenuates neuronal cytotoxicity and memory impairment in comorbid exposure to sleep-deprivation and formalin inhalation in rat model
- Open Access
- 9 February 2024
- Published by Elsevier in Brain Disorders
- Vol. 13, 100122
Containment of neuroimmune challenge by diosgenin confers amelioration of neurochemical and neurotrophic dysfunctions in ketamine-induced schizophrenia in mice
- 9 February 2024
- Published by Elsevier in Brain Disorders
- Vol. 13, 100122
Open AccessContainment of neuroimmune challenge by diosgenin confers amelioration of neurochemical and neurotrophic dysfunctions in ketamine-induced schizophrenia in mice
- Open Access
- 14 October 2022
- Published by Elsevier in Phytomedicine Plus
- Vol. 2 (4)
Dryopteris dilatata extract alleviates neuronal derangements and kidney disturbances in streptozotocin-induced diabetic nephropathy via concomitant activation of Nrf2/Bcl-2/antioxidants axis
- 14 October 2022
- Published by Elsevier in Phytomedicine Plus
- Vol. 2 (4)
Open AccessDryopteris dilatata extract alleviates neuronal derangements and kidney disturbances in streptozotocin-induced diabetic nephropathy via concomitant activation of Nrf2/Bcl-2/antioxidants axis
- 13 October 2022
- Published by Wiley in Journal of Food Biochemistry
- Vol. 46 (12) , e14477
Treatment with Ginkgo biloba supplement modulates oxidative disturbances, inflammation and vascular functions in oxygen deprived hypothyroid mice: Involvement of endothelin‐1/NO signaling pathways
A double-hit biological alteration involving exposure to oxygen deprivation in hypothyroid condition may exacerbate cellular oxidative and inflammatory disturbances comparative to a one-hit biological exposure. This study investigated the therapeutic effect of Ginkgo biloba as cardioprotective against aortic oxido-inflammatory disturbances following oxygen deprivation in hypothyroid mice. Male Swiss mice were partitioned into 5 groups (n = 6) for hypothyroidism (Carbimazole 1.2 mg/kg) and hypoxia induction. Group 1 (normal control), group 2 (hypoxic stress control), group 3 (hypoxic and hypothyroid stress), group 4 (hypoxic and hypothyroid stress and Ginkgo biloba 20 mg/kg; p.o) and group 5 (hypoxic and hypothyroid stress and Levothyroxine 10 μg/kg; p.o) for 14 days. Thereafter, serum and aorta was collected for biochemical evaluation. GBS did not up-regulate the serum thyroid hormone imbalances (tri-iodothyronine (T3), thyroxin (T4)) but maintains the TSH levels. The blood glucose level was reduced with decrease oxidative stress and inflammatory mediators in the serum/aorta indicated by inhibited redox status following treatment with GBS. Moreover, endothelin-1/nitric oxide signaling pathways were markedly regulated in the aorta. Conclusively, GBS acts as a therapeutic agent and may be consider as a potential vasodilator candidate in the management and control of hypoxic stress in hypothyroid condition. PRACTICAL APPLICATIONS: Treatment with Gingko biloba supplement abated endothelial abnormalities via elevation of nitric oxide release and suppression of endothelin activity in hypothyroid mice exposed to hypoxic hypoxia. The activity of myeloperoxidase enzyme and redo-inflammatory status was downregulated following treatment with Gingko biloba supplement in hypothyroid mice exposed to hypoxic hypoxia. Treatment with Gingko biloba supplement modulates hypothalamic-pituitary-adrenal (HPA) axis by inhibiting corticosterone release in hypothyroid mice exposed to hypoxic hypoxia.
- 13 October 2022
- Published by Wiley in Journal of Food Biochemistry
- Vol. 46 (12) , e14477
Treatment with Ginkgo biloba supplement modulates oxidative disturbances, inflammation and vascular functions in oxygen deprived hypothyroid mice: Involvement of endothelin‐1/NO signaling pathways
A double-hit biological alteration involving exposure to oxygen deprivation in hypothyroid condition may exacerbate cellular oxidative and inflammatory disturbances comparative to a one-hit biological exposure. This study investigated the therapeutic effect of Ginkgo biloba as cardioprotective against aortic oxido-inflammatory disturbances following oxygen deprivation in hypothyroid mice. Male Swiss mice were partitioned into 5 groups (n = 6) for hypothyroidism (Carbimazole 1.2 mg/kg) and hypoxia induction. Group 1 (normal control), group 2 (hypoxic stress control), group 3 (hypoxic and hypothyroid stress), group 4 (hypoxic and hypothyroid stress and Ginkgo biloba 20 mg/kg; p.o) and group 5 (hypoxic and hypothyroid stress and Levothyroxine 10 μg/kg; p.o) for 14 days. Thereafter, serum and aorta was collected for biochemical evaluation. GBS did not up-regulate the serum thyroid hormone imbalances (tri-iodothyronine (T3), thyroxin (T4)) but maintains the TSH levels. The blood glucose level was reduced with decrease oxidative stress and inflammatory mediators in the serum/aorta indicated by inhibited redox status following treatment with GBS. Moreover, endothelin-1/nitric oxide signaling pathways were markedly regulated in the aorta. Conclusively, GBS acts as a therapeutic agent and may be consider as a potential vasodilator candidate in the management and control of hypoxic stress in hypothyroid condition. PRACTICAL APPLICATIONS: Treatment with Gingko biloba supplement abated endothelial abnormalities via elevation of nitric oxide release and suppression of endothelin activity in hypothyroid mice exposed to hypoxic hypoxia. The activity of myeloperoxidase enzyme and redo-inflammatory status was downregulated following treatment with Gingko biloba supplement in hypothyroid mice exposed to hypoxic hypoxia. Treatment with Gingko biloba supplement modulates hypothalamic-pituitary-adrenal (HPA) axis by inhibiting corticosterone release in hypothyroid mice exposed to hypoxic hypoxia.